Author

Ebba Sohlberg

Karolinska InstitutetORCID 0000-0003-1942-0040Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell signaling & trafficking· 2 Assay:proteomics· 2 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1

Frequent Co-Authors

Karl‐Johan MalmbergiD· 2 shared Ang Lin· 1 shared Anna Smed‐SörenseniD· 1 shared Anucha PreechanukuliD· 1 shared Benjamin Hammond· 1 shared David M. MarkovitziD· 1 shared Dimitra PeppaiD· 1 shared Douglas C. MacDonaldiD· 1 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Karl‐Johan MalmbergORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologyCytotherapyPeer-reviewedOct 25, 2025

Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines

Jonida Kokiçi, Helena Arellano-Ballestero, Benjamin Hammond…·Dimitra Peppa

This study expands adaptive NKG2C+ NK cells from HBV-infected donors, showing enhanced ADCC and anti-hepatoma activity.

5 citations

humanflow cytometry

𝕏 PostBluesky

ImmunologyPLoS PathogensPeer-reviewedMay 7, 2025

A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansion

Meng Yu, Ang Lin, Faezzah Baharom…·Anna Smed‐Sörensen

This study evaluates the antiviral and immunomodulatory effects of H84T BanLec on human immune cells and IAV-specific CD8 T cell responses.

1 citation

humanproteomics

𝕏 PostBluesky

ImmunologyMedPeer-reviewedOct 17, 2024

Targeting HLA-E Positive Cancers with a Novel NKG2A/C Switch Receptor

Michelle Sætersmoen, Ivan S. Kotchetkov, Lamberto Torralba‐Raga…·Karl‐Johan Malmberg

This paper develops a novel chimeric A/C switch receptor to target HLA-E positive cancers, showing enhanced anti-tumor activity while avoiding off-tumor toxicity.

33 citationstop 4%

humanproteomics

𝕏 PostBluesky